肝脏疾病细胞疗法进展及前景展望
作者:佚名 文章来源:本站原创 点击数: 更新时间:2009-4-29
印度医学科学研究所
Sanjeev K Gupta
Hepatology Digest: You have done great work in the area of liver cell therapy but it appears most cell therapy studies are still in the lab. In your opinion, when can cell therapy be used in clinical treatment of liver diseases?
Pro. Sanjeev Gupta: In fact, cell therapy for liver disease has been attempted for nearly two decades and some 100 patients worldwide have already been treated with liver cell therapy. The initial experience that has already been accumulated indicates that more work needs to be done. What we have certainly learned is that cell therapy is safe to be done in patients and that there are certain types of precautions that will need to be taken to make sure there are no complications. What we have learned is that for the maximum efficacy of cell therapy, certain types of manipulations need to be done, such that the number of transplanted cells can grow in the liver to correct various diseases. Having said that, what this implies is that future efforts for cell therapy are likely to be much more effective than what has been done so far.
Hepatology Digest: Is the end-goal of that[1] [2] [3] [4] [5] 下一页
对此文章有什么疑问,请提交在乙肝论坛